Hydrocortisone Probutate
A unique double-ester derivative of hydrocortisone designed to improve skin penetration and local anti-inflammatory potency while minimizing systemic absorption. It is used as a topical corticosteroid for inflammatory skin conditions. Once absorbed into the skin, it is metabolized to active hydrocortisone to exert its therapeutic effect.
Berat Molekul
488,6000 g/mol
LogP
4,20
TPSA
107,00 Ų
Lipinski RO5
Lulus
Area Terapeutik
Mekanisme Kerja
Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.
Struktur 2D
Cite this structure
Embed this structure
SMILES
CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
InChI
InChI=1S/C28H40O7/c1-5-7-24(33)35-28(22(31)16-34-23(32)6-2)13-11-20-19-9-8-17-14-18(29)10-12-26(17,3)25(19)21(30)15-27(20,28)4/h14,19-21,25,30H,5-13,15-16H2,1-4H3/t19-,20-,21-,25+,26-,27-,28-/m0/s1
Molecular Formula
C28H40O7
HBD / HBA
1 / 7
Ikatan yang Dapat Dirotasi
9
Atom Berat
35
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Pertanyaan yang Sering Diajukan
A unique double-ester derivative of hydrocortisone designed to improve skin penetration and local anti-inflammatory potency while minimizing systemic absorption. It is used as a topical corticosteroid for inflammatory skin conditions. Once absorbed into the skin, it is metabolized to active hydrocortisone to exert its therapeutic effect.
Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.
Yes, Hydrocortisone Probutate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200953. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 636398. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="hydrocortisone-probutate"></div>
Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/hydrocortisone-probutate/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>
Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/hydrocortisone-probutate/
Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/hydrocortisone-probutate/)
Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="hydrocortisone-probutate"></drugfyi-drug>